Severe transient postoperative memory deficits among epilepsy patients with resection from one temporal lobe may be indicative of increased risk for amnesia had more extensive removal of mesial structures occurred. Immediate postoperative testing may provide some validation for risk of amnesia as predicted by the intracarotid sodium amobarbital memory test (IAP-M). Thirty patients (24 not considered at risk for amnesia and 5 who failed the IAP-M) were tested on the first, second, and third days following resection from the right or left temporal lobe. Results suggest that the IAP-M paradigm used does not necessarily predict postoperative memory performance.
INTRODUCTION
Since the original reports of unexpected amnesia following unilateral temporal-lobe resection for the treatment of medically intractable epilepsy (Milner, 1958; Milner & Penfield, 1955) , the intracarotid sodium amobarbital procedure (IAP) has become widely used to assess risk of postoperative amnesia. The IAP memory test (IAP-M) is thought to test the patency of brain structures important for memory. Patients who are unable to remember test items introduced after drug injection (anaesthetisation) into the proposed surgical hemisphere are believed to have additional damage in the contralateral hemisphere and could be at risk for postoperative amnesia. Therefore, these patients may not be offered surgery, or they may receive a limited resection with sparing of the mesial structures.
In recent years controversy has arisen surrounding the validity of the IAP-M procedure (Jones-Gotman, Barr, Dodrill, Gotman, Meador, Rausch,
